Language selection

Search

Patent 1185153 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1185153
(21) Application Number: 1185153
(54) English Title: AGENT FOR DETECTING GLUCOSE IN BIOLOGICAL FLUIDS
(54) French Title: AGENT POUR LA DETECTION DU GLUCOSE DANS LES LIQUIDES BIOLOGIQUES
Status: Term Expired - Post Grant
Bibliographic Data
(51) International Patent Classification (IPC):
  • G01N 33/66 (2006.01)
  • C12Q 1/28 (2006.01)
  • C12Q 1/54 (2006.01)
(72) Inventors :
  • KOHL, HELMUT (Germany)
(73) Owners :
  • DADE BEHRING MARBURG GMBH
(71) Applicants :
  • DADE BEHRING MARBURG GMBH (Germany)
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued: 1985-04-09
(22) Filed Date: 1982-10-28
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
P 31 42 862.2 (Germany) 1981-10-29

Abstracts

English Abstract


Abstract of the disclosure:
An agent for detecting glucose in biological
fluids is described, which is essentially composed of an
adsorbent matrix, a glucose oxidase, a peroxidase and a
chromogen. This agent contains a nitrate and can contain
a UV absorber.


Claims

Note: Claims are shown in the official language in which they were submitted.


THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE PROPERTY
OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. An agent for detecting glucose in biological fluids,
which essentially comprises an adsorbent matrix containing a
chromogen, a glucose oxidase, a peroxidase and a nitrate.
2. An agent as claimed in claim 1 which also contains
a UV absorber.
3. An agent as claimed in claim 1 wherein the nitrate
is a nitrate of an element of the first group of the periodic
table or is ammonium nitrate.
4. An agent as claimed in claim 2 wherein the UV absorber
is a derivative of benzoic acid, of benzophenone, of oxalic
acid or is a benzotriazine.
5. An agent as claimed in claim 3 wherein the nitrate
is ammonium or sodium nitrate.
6. An agent as claimed in claim 4 wherein the UV absorber
is 2,2'-dihydroxy-4-methoxybenzophenone and 2-hydroxy-4-methoxy-
benzophenone-5-sulfonic acid.
7. A process for the preparation of an agent as claimed
in claim 1 which comprises treating a support with an aqueous
solution which contains the ntirate, the glucose oxidase, the
peroxidase and the chromogen.
8. A process as claimed in claim 7 in which, after drying,
treating the support with a solution which is not miscible
with water and which contains a further UV absorber and a
water-repelling agent.
9. A process as claimed in claim 8 in which the solution
also contains a UV absorber.

Description

Note: Descriptions are shown in the official language in which they were submitted.


L r
- 2
~OE ~1/8 012
The inver,tion relates to an ac3ent for detecc;ng
glucose in biological fluids, ~hich essentially com~
prises an adsorbent matrix~ a glucose oxidase, a peroxid-
ase and a chromogen as re3gent anci contains a nitrate and,
optionally~ a UV absorber.
Diabetes mellitus is a chronic disease ~hich must
be continuously monitored. It has proved to be reason~
able for the diabetic to monitor his o~ln metabolic status
afte,r ins~ruct;on by ~he phys;cian ;n order to be able,
1~ if necessary, immediately to adjust the necessary insulir
dose ~o suit ~he changing requiremcnts. The check of
metaboLism is carried out sush that the conten~ of
~lucose in the urine or in the blood is routineLy
determined. In general, the diabetic determines his O~il
urinary glucose value semiquantitatively, whilst~ in
contrast, quantitative measuremen~ of blood sugar is
carried out by an expert.
The determination of urinary glucose sl1ould cover
a concentration rancge up to about 5 g of c3lucose/100 ml
~- ~f urine.
hi present, there arè t,to met,hods for rapid semi--
~uantitative C~etermiQatiOn o-F c3lucose:
1. Test ;ablecs accordincJ to the non-specific reduction
r,letllocl o-F ~ EDlKr and
~ Test strips ~hich are irDprec~nated ~ich c~lucoce oxidase,
'

' 3
-- 3 --
which reacts soecifically, a chromogen and a peroxidase.
The glucose oxidase in the test strips catalyzes
the ox;dation of glucose with oxygen to for~, gLuconolact-
one and hydrogen peroxide. In a subsequent non-speçifi~
reaction~ ehe latter oxidizes a chromogen, ~i~h peroxid-
ase catalysis, to g;ve a dyestuff.
The t~o methods ~entioned are associated uith dis-
ad~antages: -
! Th2 reduction method is non-specific, since
other reducing com?ounds, such as, for exanple, galactose,
are also de~ected. Furtherrrlore, i~ is necessary to use
corrosive reagents for this rnethod (G. Friedrich~ "Der
;nformierte Arzt" 8 (9), Off-print, 1~80). In addition,
~he reaction is associa~ed ~ith a not inconsiderable
'l~ evolution ~f heat alld ~iih an interle~ g forr,7atiun of
foam. The performance of ~he tests ~lith tablets and ~est
tubes is elaborate, inconvenient and costly.
The same applies to the second rnethod of deterrnin-
at;on~ S;nce thc semiquantitative test strips for urine
hitherto only comprise a ran~e of indication up to a
axilnum of 2 Q of glucose/100 ml of urine~ they are un-
suitable for day in day-out routine testing, since higher
glucose concentrations should also be de~ected.
In order to get round this a'isadvantage, the use
of a diLuting de~ice has been proposed t~orge and
Schlebusch, "t1edizinische Klinik" 75, 537-591, '1980~.
~;lutir-g devices of this type are disadvan~ageous for
simple routine deterlnination, since man-,pulationc are
expected of the unpractised diabetic, ~lith ~hich he is

~ ~?t --
not con~ersant (pipetting, diluting and evalua-ting). The
hygienic requirements are Yery stri~t and cannot al~lays
be fulfilled~
In contrast, it is intended to provide the dia-
betie with a simple tes~, which is easy to learn, ishygienieally aceeptable ancl ~Ihich eomprises as largD a
eoncentration range as possible.
Thus the objeet of the present invention was an
improved agent for determining glucose in biological
fluids~
It is kno~n, from Bioehem~ Journal 42, 221 (1948),
that glueose oxidase is inhibited as much as 13 % by
sodium nitrate~ This inhibitory effeet is so small for
glucose test strips, in ~hich a large exeess of enzymes
1~ ;s employed, that no use has hilherto Deen made of il.
Our own experinents showed that a eorresponding rapid test
for deterrnining glucose ;s not inhibited by nitrates.
Conversely, it has no~ been found, surprisingly,
that by impregnating glucose test strips ~ith nitra~ces,
their range OT indication is signi-ficantl) enlarged,
partieular~y uhen hydrophobic films (IJ~ ~lishinsky in
Quality Control ;n Clinical Chermistry; Amido, Rosalhi and
~. Kampen, page 425, de Gruyter, Berlin 1975) are used.
By this means the range of indica~:ion of 2 CUstOnlary
semiquant;tative test reg;on, ~Ihich extends to a max;murr,
of a'~out 2 9 o~ glucose/1~0 ;nl of urine, can be extended
to rnore than , g of glucose/lOO rnl of urine. These modi-
fied tesc strips chus comply, in respect of their range
of use, with the rec-uirements placeo on a sirnple dia~nos~:ic

S -
aid by a diabetir. Furthermore~ a ~est strip of this
type fulfils the hygienic dernands~
Furthermore, it has been found that ~he resist~
ance of these test strips to ligllt can be improved oy the
5 ~ddit;on of UV absorbers.
The object described above has now been achieved
by ~he agent containing, in addition ;o the cus-tomary
components, a nitrate and, optionally, a llV absorber.
Accordingly, the inveneion relates to an agerlt
10 ~or the detection of glucose in biological fluids, essen-
tially composed of an adsorbent matrix~ containing a
chromogen, a glucose oxidase, a peroxidase and, option-
ally, a stabilizer, which contains a nitrate and, optionally,
a UV absorber.
~h. inver,tior~ furthcr rclate~ to the use o-f ~rnmon-
ium nitrate or a nitrate of an element of the first group
of the periodic table, ammonium and sodi~m nitrate being
preferred. Examples of UV absorbers which can be used
are the derivatives of benzophenone, of benzoic acid,
20 oxalic acid or of benzotriazine.
Compounds of this type are described in "IJllrllanns
Enzy~;lopadie der technischen Chemie" ~lJllrnann's Encyclo-
pedia of Industrial Chemistry), ~th edition, volu~e 15
pa~e 259r Verla~ Chemier Weinheim, Federal Republic of
25 Germany. 2,2'-Dihy~roxy-4-methoxybenzophenone (Cyasorb
UV 24, Arnerican Cyanamide)t 2-~ydroxy-4-methoxybenzo~
phenone-5-sulfollic acid (UV absorber HMBS "Riedel",
Riedel-de Haen AG, SeeLze, Federal Rep~blic of Gerrr!any)
or dihydroxybenzGpllenone are preferred.

The agent accordin~ to the invention is thus com-
posed o~ an ~idsorbing support matrix, in i~hich a glucose
oxidase, a peroxidase, a chromogen, a i~ater-soluble
nitrate and, optionally, a UV absorber are impregnat2di.
A(l absorbent plane structures of natural or synthetic
or;~in can be used as the support matrix, such as, for
example, non-uoven fabrics, papers, asbes~os or polymer
f;lms.
The agent is advansageously prepared such that
the chromogen, the buffer and the enzymes, together with
the nitrate, in aqueous solution are appliecl to the test
pciper. The UV absorber can also be dissolved in this irn-
pregnating solution. I~ is also possible to apply the UV
absorber i~ith a iJater repelling agen~c to the support
ma~rix in a further steo. The sequence of imprec~rla~ion
steps is arbitrary; it is also possible to start uith the
application of the i~ater-repel~ing ~igent. A process has
proved effective in uhich initially an indicator base
paper is impregnated ~ith chromogen, buffer, enzymes,
~etting agent, stabilizer, a i~ater soluble nitrate and a
UV absorber. Then a further UV absorber and a ~Jater-
repelling a~ent, for example ethylcellulose, dissolved in
an organic solvent, ~hich is not miscible with Jater,
such a~ toluene, are applied.
The preferreo process for ~he ?repciraiion of an
agen. according to the .nvention ~hus co~priscs t~o steps.
hfter drying~ the reaction support is lar,ina~ecl on~o a
plastic film for easier manipulatiorl.
The amount of nitrate :sed in each case is

53
- 7 -
no~ critical; it can be adjusted to sui~ the particular
envisa~ed use, that is to say the range of concentration
to be co~ered. It can be between 0.1 and 7 X Sv:~) rela-
tive to ammonium nitrate. A concentrat;on bet~leen 0.3
S and ~.0 X (v:~3 is preferred.
The amount ~f UV absorber used is also not criti-
cal~ ln general, a larger amount of UV absorber is
emplo~ed for a larger amount of nitrate. The maximum con-
centration of the UV absorber is limited by ;-ts solubility
in the solvent chosen. The cor,centrations can vary between
Or1 and ~.0 % ~:v), however~ a concentration range
betweel- 0.4 and 3.0 X (~:v) is preferred.
In order to use the agent descrihed, it is
br;efly dipped into the ~u;d to be tested. h graded
~5 coLor reaction develops, depending on the content of glu-
cose in the fluid, which can be graded semiquanti~atively
up to 5 9 of glucose/100 ml oF urine.
The advantage of the invention emerged f-rom com-
para~ive investigat;ons w;th rapid diagnostic aids accord-
in~ to the state of the ar~.
Three test strip papers ~ere prepared accordingto Examples 1 to 3, of which 1 a represents the state of
the art. 1 b was prepared using a water-soluble ni~ra-.e~
1 c corresponds to 1 b, but the paper was additionall
;mpregnated ~lith a UV absorber.
The follo~;nrJ tests ~ere carried out ~ith the
f;nished p 2 p ers
Paperc 1 a, 1 b and 1 c were eYposed to sunli~ht~
After about 20 l~inutes of this, 1 b riscolored to such

~L ~5 ~
an intense green that it gave a false positi~e result on
subsequent ~etting ~/ith a glucose-free solotion. In con-
trast, papers 1 a and 1 c did not change their original
color even after 60 rnin~
In a further series of tests, papers 1 A ancl
1 c uere dipped in samples of urine ~Ihich contained 50,
15n, 500, 1,500~ 3,000 and 5,000 mg of gluGose/100 ~nl oF
urine. The conc~ntration s~eps up to 1~,500 Ing/dl could be
easily clifferentiated with paper 1 a, ~hiLst the two
10 higher glucose concentrations ~ere not distinguished. In
contrast, the entire spectrum from 50 mg of glu~ose/100 ml
oF urine up to 5,000 mg of glucose/100 ml of urine could
be differentiated with paper 1 c.
The invention is illustrated in more detail by
1~ means of the -;ollo~Jing examples.
Example 1 t Paper 1 a
_ .
Solution 1 The following lJere dissolved in 100 ~nl of
0.1 M citrate buffer, pH 5.5:
0.5 cg of gela-tin
20 7.0 mg of tartrazine
0.6 g oF o-tolidinc dihydrochloride
0.2 g of peroxidase
0.~ 9 of glucc)se oxidase
1,0 g o~ polyethylene gLycol 1500.
Paper 2316 of Schle;cher anci Schull, Dassel,
Federal Republic of Gernlany, ~,las inlpregna~ed ~ith this
irnpregnation solution. After drying at 80C in an oven,
the paper uas subjected to a second3ry iMpregnation ~/-ith
Solution 2 containing 0 6 CJ Of ethylcellulose in 1G0 ~nl
: . .

s-j ~Lr~
of toluene.
Exa,-,lple 2 ,t Paper 1 b
A pa~er 1 b ~as prepared in accordance ~ith
Exampl~ 1, but an add;tional 2 9 of ammonium nitrate were
5 dissGlved in solution 1. The secondary impregnation was
h so lu~ i on 2 .
Example 3 / Paper 1 c
_ _ _
Th e f o l lOh'i ng were additionally di sso lved i n
100 ml of ~he impregnation solution 1 according to
Example 1:
2.0 ~ o~ ammonium nitrate and
1rO ~ OT UV absorber HMBS "Riedel"~
The following lere dissolved in 100 ml of tol~ene
for ~he seconclary impregnation:
0.5 ~, of ethylcellu!ose and
2.0 9 of Cyasorb, Cyanamide.
Papers 1 a, 1 b and 1 c showed ~he propelties
described abuve.

Representative Drawing

Sorry, the representative drawing for patent document number 1185153 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC from MCD 2006-03-11
Inactive: Expired (old Act Patent) latest possible expiry date 2002-10-28
Inactive: Reversal of expired status 2002-04-10
Inactive: Expired (old Act Patent) latest possible expiry date 2002-04-09
Grant by Issuance 1985-04-09

Abandonment History

There is no abandonment history.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Registration of a document 1997-10-27
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
DADE BEHRING MARBURG GMBH
Past Owners on Record
HELMUT KOHL
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 1993-11-03 1 18
Claims 1993-11-03 1 29
Abstract 1993-11-03 1 8
Drawings 1993-11-03 1 12
Descriptions 1993-11-03 8 202